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Abstract
Background: Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymphoma
development than uninfected cats. Furthermore, an increased exFeLV transcription has been detected in
lymphomas compared to non-malignant tissues. The possible mechanisms of lymphoma development by exFeLV
are insertional mutagenesis or persistent stimulation of host immune cells by viral antigens, bringing them at risk
for malignant transformation. Vaccination of cats against exFeLV has in recent years decreased the overall
infection rate in most countries. Nevertheless, an increasing number of lymphomas have been diagnosed among
exFeLV-negative cats. Endogenous feline leukemia virus (enFeLV) is another retrovirus for which transcription has
been observed in cat lymphomas. EnFeLV provirus elements are present in the germline of various cat species
and share a high sequence similarity with exFeLV but, due to mutations, are incapable of producing infectious
viral particles. However, recombination between exFeLV and enFeLV could produce infectious particles.
Results: We examined the FeLV expression in cats that have developed malignant lymphomas and discussed the
possible mechanisms that could have induced malignant transformation. For expression analysis we used
next-generation RNA-sequencing (RNA-Seq) and for validation reverse transcription quantitative PCR (RT-qPCR).
First, we showed that there was no expression of exFeLV in all samples, which eliminates the possibility of
recombination between exFeLV and enFeLV. Next, we analyzed the difference in expression of three enFeLV
genes between control and lymphoma samples. Our analysis showed an average of 3.40-fold decreased viral
expression for the three genes in lymphoma compared to control samples. The results were confirmed by
RT-qPCR.
Conclusions: There is a decreased expression of enFeLV genes in lymphomas versus control samples, which
contradicts previous observations for the exFeLV. Our results suggest that a persistent stimulation of host
immune cells is not an appropriate mechanism responsible for malignant transformation caused by feline
endogenous retroviruses.
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Background
Endogenous feline leukemia virus (enFeLV) sequences
are found in the genomes of domestic cats (Felis catus)
and related wild cat species [1,2]. These endogenous
provirus sequences are transmitted vertically through
the germ line and exhibit high similarity to exogenous
feline leukemia virus (exFeLV) species, which are part of
the genus of gammaretroviruses [3-6]. ExFeLV are envel-
oped viruses with an RNA genome. The viral genome is
composed of two single-stranded positive-sense messen-
ger RNA (+mRNA) chains inside a viral particle. Before
replication, the viral genome is converted to DNA and
then integrated into the host genome. The genome con-
tains three viral genes necessary for replication, in the
following order: 5′-gag-pol-env-3′ [7,8]. On both ends of
the viral genome, there are LTR (long terminal repeats),
which contain regulatory sequences. Although, tran-
scription and translation of enFeLV proviruses were de-
tected in various tissues and cell lines, no infectious
viruses are produced, due to mutations within essential
parts of the viral genome [9-11]. However, recombination
between enFeLV sequences with exFeLVs can generate
infectious virus particles [11-15].
ExFeLV infection has been associated with the emer-
gence of lymphomas in cats. Infected cats have a higher
risk for tumor development compared to uninfected
[16]. Since exFeLV (as well as enFeLV) is capable of inte-
grating its viral sequences into the host cell’s genome,
insertional mutagenesis and subsequent activation of cel-
lular oncogenes by regulatory elements on the viral LTR
region is one possible mechanism responsible for malig-
nant transformation by exFeLV [17-19]. Another poten-
tial tumorigenic effect of the virus would be the
persistent stimulation of immune cells by viral antigens
bringing them at risk for transformation [20]. Due to the
implementation of vaccination and elimination programs
against exFeLV, the infections rates are decreasing in
some regions of the world [21,22], while in other regions
the prevalence of the virus remains high [23]. However,
recent data suggest that increasing numbers of lymph-
omas are found among virus-negative cats [24-27]. The
transcription of enFeLV has been observed in feline
lymphomas [28,29], but it is still unclear if enFeLV could
be another cause of malignant transformation.
In this study, we examine the potential influence of
FeLV expression in cats that have developed lymphomas
and discuss the possible mechanisms that could have
induced malignant transformation. To achieve that, we
first sought to confirm the absence of exFeLV, which
would allow an independent evaluation of the effects of
enFeLV expression. We then investigated the difference
in enFeLV expression between two conditions: non-
malignant lymph nodes (control) and feline intestinal
lymphoma tissues (tumor samples). Here we applied two
methods to determine the transcription of exFeLV and
enFeLV: next-generation RNA-sequencing (RNA-Seq)
[30] and for validation -reverse transcription quantitative
PCR (RT-qPCR) [31]. Previous studies have measured
the expression of FeLV using RT-qPCR [32]. This study
presents the first investigation of the expression of FeLV
for domesticated cats using next-generation sequencing
technologies. Using RNA-Seq, it is possible to analyze
the transcriptome at a higher resolution, with a larger
dynamic range [30].
Results
No exFeLV expression detectable by RNA-Seq and RT-qPCR
The transcriptomes from three control and five tumor
cat samples were sequenced. The mean number of se-
quenced reads in the control samples was 71.33 million,
and in the tumor samples was 73.20 million (Additional
file 1). We mapped the reads to the reference genomes
of both enFeLV and exFeLV (see Methods section for
the virus details). As a pairwise sequence alignment re-
ported that the analyzed strains of enFeLV and exFeLV
are 74.10% identical, we counted only the reads mapped
to virus specific parts of U3 regions in the LTR (Figure 1)
to estimate the enFeLV or exFeLV specific expression
strength. These virus specific regions were suggested by
Tandon et al. [33,34]. Table 1 shows the raw number of
mapped reads (MAPQ > 20) to virus specific regions. In
control samples, on average 46.33 reads mapped to the
enFeLV specific region (35 bp) and in tumor samples, on
average 14.80 reads mapped to the same region. In con-
trast, no reads mapped to the exFeLV specific region
(22 bp) in both conditions, indicating that the samples
contained only enFeLV viral RNA.
We next used RT-qPCR to confirm the results ob-
tained by RNA-Seq. The tissue samples were investi-
gated for FeLV RNA using the previously illustrated
virus specific regions as RT-qPCR probes. Table 1 sum-
marizes the individual results. We detected no exFeLV
probe copies among all tested samples, while on aver-
age 5.90 × 105 standardized enFeLV probe copies were
detected in the control samples vs. 1.28 × 105 that were
found in the tumor samples (Table 1).
Decreased enFeLV expression levels in tumor compared
to control samples
We investigated the expression level of the three enFeLV
genes (gag, pol and env) for control and tumor samples
using RNA-Seq. Table 2 shows the standardized number
of mapped reads. On average, 147.84 × 10−6 standard-
ized reads mapped to the gag gene in the control sam-
ples, whereas 40.28 × 10−6 standardized reads mapped
to the same gene in tumor condition. Thus, a 3.67-fold
decrease of gag expression was observed in tumor sam-
ples. We obtained similar results with the pol and env
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genes. On average 152.69 × 10−6 standardized reads
mapped to the pol gene in control and 50.03 × 10−6
mapped to the pol gene in tumor condition, indicating a
3.05-fold decrease of pol gene expression in tumor sam-
ples. As for the mapping to env gene, we found that in
the control condition on average 353.28 × 10−6 stan-
dardized reads mapped, while on average 98.85 × 10−6
standardized reads mapped to the env gene in tumor
samples, representing a 3.57-fold decrease of env expres-
sion in tumor compared to control.
To test if the expression of each enFeLV gene is sig-
nificantly different in control compared to tumor condi-
tion, we performed three two-sided Mann–Whitney U
tests (with the significance level chosen to be 0.05). For
the pol and env genes, tests did not show a significant
difference (p-value = 0.07143 for both genes) in the
expression between control and tumor samples. For the
env gene we observed a significant difference in expres-
sion (p-value = 0.03571) between the two conditions,
towards the control condition. The fold change and the
performed tests clearly show that there was no increase
in expression in the tumor samples.
We then performed RT-qPCR targeting the enFeLV
specific U3 region to confirm the findings from RNA-
Seq. The amounts of RT-qPCR detected viral RNA were
standardized by the copy numbers of feline GAPDH,
Figure 1 Pairwise sequence alignment with Needle. The illustrated viral specific regions are in U3 FeLVs regions. The regions are framed in red and
blue colour, which corresponds to enFeLV and exFeLV specific regions, respectively. The numbers present nucleotide position in viral genomes.
Table 1 RNA-Seq and RT-qPCR results for expression of exFeLV and enFeLV virus specific regions
Condition Cat No. of reads mapped to specific regions (MAPQ > 20) RT-qPCR
exFeLV probe enFeLV probe enFeLV GAPDH enFeLV/1.00 × 106 GAPDH exFeLV
control A 0 24 7.09 × 107 1.04 × 108 6.78 × 105 Not detected
B 0 83 1.72 × 108 3.43 × 108 5.01 × 105 Not detected
C 0 32 NA NA NA NA
tumor D 0 4 9.52 × 106 1.37 × 109 6.97 × 103 Not detected
E 0 11 1.25 × 108 5.33 × 108 2.34 × 105 Not detected
F 0 16 1.56 × 108 7.61 × 108 2.05 × 105 Not detected
G 0 16 1.24 × 108 9.78 × 108 1.27 × 105 Not detected
H 0 27 7.92 × 107 1.22 × 109 6.49 × 104 Not detected
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which was used as a reference gene for total RNA levels
(Table 1). Within all tumor samples, enFeLV RNA copies
per 1.00 × 106 copies of GAPDH were found to be lower
in comparison to the control samples. When compared to
the average enFeLV expression level of control samples,
the mean enFeLV expression level in the tumor samples
was decreased 4.60-fold. Applying a two-sided Mann–
Whitney U test (with the significance level of 0.05), we de-
termined that there was no significant (p-value = 0.09524)
difference in the standardized copy numbers of RNA
detected from the enFeLV specific U3 region between
control and tumor conditions.
Discussion
Investigation of exFeLV infection
RNA-Seq analysis showed that there were no reads mapped
to the exFeLV specific regions. No evidence of infection
with exFeLV was confirmed by RT-qPCR. Additionally,
no exFeLV antigen could be detected by a commercial
exFeLV ELISA test (SNAP FIV/FeLV Combo Test,
Idexx Laboratories).
EnFeLV transcriptome: control vs. tumor samples
As infections with exFeLV could not be detected among
the here tested cats, transcription of the enFeLV in the
investigated animals was not affected by interactions
with exFeLV, and should have allowed a valid compari-
son of enFeLV expression levels between tumor and
control tissues.
By the means of RNA-Seq: 3.40-fold less viral reads
were detected among the tumors compared to control
samples. Confirmation of these findings was done by
RT-qPCR, where similar values were obtained: the mean
enFeLV copies per 1.00x106 GAPDH for all tumor sam-
ples turned out to be 4.60-fold lower compared to the
mean value of the control samples. It should be noted
that the acquired enFeLV expression levels from RNA-
Seq were based on the expression of three enFeLV genes
while, in contrast, RT-qPCR targeted only the viral U3
region. Mann–Whitney U tests on enFeLV gene counts
showed that enFeLV genes transcription in tumor sam-
ples was not elevated compared to control tissues, which
seems contradictory to observations for the exogenous
virus, since a previous study found higher exFeLV viral
loads in lymphomas compared to non-malignant tissues
[35]. As the exFeLV env gene is supposed to have im-
munosuppressive properties, the increased viral env
transcription could possibly prime the development and
progression of malignancies [36]. In contrast to the
exFeLV, our results demonstrate that enFeLV expression
levels are not higher on average among all the investi-
gated tumor samples compared to the control tissues.
These findings can at least be applied for the here exam-
ined exFeLV negative tumors. Nevertheless, one must
also take into consideration that a reason for a decreased
expression of enFeLV in tumor samples could be the in-
creased transcription of certain cellular transcripts (an
increase in the overall mRNA expression is not a rare
case for tumors [37,38]), which could lead to the ob-
served decreased proportion of the other mRNA species,
including the amount of enFeLV. That would have to be
tested by future studies.
In summary, no exFeLV sequences could be detected
in the analyzed samples. Although, increased expression
of endogenous retroviruses (ERV) has been observed in
feline lymphomas [28,29], our data suggest no general
increase in the enFeLV transcription levels in lymphoma
compared to non-malignant lymphatic tissues. A recent
publication investigating human Hodgkin’s lymphoma
cells [39] found similar observation of no increase in
ERV expression in lymphoma cells compared to normal
blood cells. We speculate that the potential impact of
enFeLV on the formation of lymphomas seems to be dis-
tinct from the exogenous virus. Thus, possible effects of
enFeLV on lymphoma development are presumably not
due to immunosuppression induced by the expression of
viral genes. For enFeLV, high levels of insertional poly-
morphism have been already described in cats [40]. That
led us to believe that insertional mutagenesis of cellular
genes by proviral sequences may be a more important
mechanism responsible for malignant transformation
than viral gene expression induced immunosuppression.
However, more data are required to conclusively show
that, since other transponsable elements might also play
a role in the malignant transformation.
Conclusions
We show no expression of exFeLV in all analyzed sam-
ples. On the contrary, a clear signal indicates the expres-
sion of enFeLV in all investigated samples, with no
significant increase in enFeLV expression detected in
tumor samples compared to control samples. This indi-
cates that the potential tumorogenesis caused by feline
Table 2 RNA-Seq results for enFeLV genes expression
Condition Cat Standardized no. of mapped
reads to enFeLV genes [x 10−6]*
gag pol env
control A 151.49 132.68 256.50
B 212.27 244.04 612.54
C 79.76 81.35 190.80
tumor D 9.91 16.72 22.36
E 29.54 35.68 71.67
F 22.90 43.40 105.23
G 82.13 83.07 135.06
H 56.90 71.26 159.91
*Standardized by total number of reads (MAPQ > 20).
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endogenous retroviruses cannot be well explained by an
immunosuppression mechanism. Further work is neces-
sary to investigate how tumorogenesis in this case
occurs.
Methods
Animal samples
Tissues of eight domestic cats presented to the clinics of
the University of Veterinary Medicine Vienna were in-
cluded in this study (Table 3). These samples include five
lymphoma tissues (tumor samples) and a control group
consisting of three lymph nodes. Lymphomas were diag-
nosed based on routine histopathological examination.
Additionally, phenotyping by immunohistochemistry
was done for all lymphomas, except for cat D, at which
diagnosis was based on histology only. Lymph nodes
samples were taken from cats without malignancies that
were presented for other diseases: chronic kidney disease
(cat A), thromboembolism (cat B) and suspected feline
infectious peritonitis (cat C).
Ethics statement
Animal samples were taken from cats presented to the
clinics of the University of Veterinary Medicine Vienna
that have been euthanized for clinical reasons. The pet
owners agreed to the use of data and sample material for
research and educational purposes. The experiments
were discussed and approved by the institutional ethics
committee in accordance with GSP guidelines and na-
tional legislation.
RNA isolation
All tissue samples were mechanically homogenized on a
MagNALyser instrument (Roche Diagnostics, Mannheim,
Germany) using 1.4 mm ceramic beads (PeqLab, Erlangen,
Germany) at the following settings: 6000 rpm for 30 sec.
Subsequently, total RNA was isolated utilizing the RNeasy
Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s recommendations. Possible contamination
with genomic DNA (gDNA) was removed by an on-
column DNase I (Qiagen) treatment. RNA quality was
investigated by capillary electrophoretic separation of
the samples on the Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA) and subsequent
determination of RNA integrity numbers (RIN). Only
samples with a high degree of intact RNA, as deter-
mined by RIN-values > 8 were used for further analysis.
RT-qPCR quantification of enFeLV and exFeLV RNA levels
RNA levels of enFeLV and exFeLV were determined in
tissues by RT-qPCR using two virus-specific TaqMan
probe assays targeting the U3 regions of enFeLV and
exFeLV (enFeLV-U3-1, FeLV-U3-exo) as previously de-
scribed [33,34]. Viral copy numbers were then stan-
dardized to the expression levels of the feline GAPDH
gene [41].
Illumina RNA-sequencing
1 μg total RNA from each sample was used as the start-
ing material for the preparation of cDNA libraries and
adjacent RNA-sequencing analysis on a Genome
Analyzer IIx system (Illumina Inc., San Diego, CA,
USA). Library preparation, including poly-A mRNA
purification, and the following next generation sequen-
cing were performed as described in [42], except for the
implementation of paired-end sequencing in this study.
After 41 sequencing cycles, resulting in one 41-
nucleotide (nt) sequencing read per cDNA fragment, a
second sequencing round was executed starting from
the opposite end of the molecules. Thus, two 41-nt reads
were generated for each cDNA fragment revealing the
sequence information starting from both ends of the ori-
ginal mRNA template.
Pairwise sequence alignment
EMBOSS Needle [43] was used to perform and visualize
the global sequence alignment between exFeLV and
enFeLV. The tool was used with the default parameters,
version 6.6.0.
Table 3 Sample description
Cat Age Gender Tissue Localization Histological classification
control A 11 y 6 m female, neutered Lymph node Popliteal -
B 4 y 11 m male, neutered Lymph node Mandibular -
C 5 y 6 m female, neutered Lymph node Popliteal -
tumor D 10 y 5 m female, neutered Lymphoma Intestinal Monomorphic lymphoma
E 10 y female, neutered Lymphoma Intestinal Peripheral T-cell lymphoma
F 8 y 11 m female, neutered Lymphoma Intestinal Lymphoblastic T-cell lymphoma
G 5 y 7 m female, neutered Lymphoma Intestinal Lymphoblastic lymphoma
H 15 y 2 m male, neutered Lymphoma Intestinal Diffuse large B-cell lymphoma
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Mapping and counting RNA-sequencing data
Mapping was done using NextGenMap version 0.4.8. [44].
The non-default parameters were: mode (−m) 1, which uses
semi-global alignment for mapping. Identity threshold (−i)
was set to 90%. The reads were mapped to the reference
consisting of the enFeLV genome [GenBank:AY364318.1]
and the exFeLV genome [GenBank:M18247.1].
Mapped reads were filtered for mapping quality
MAPQ > 20 using samtools, version 0.1.18[45]. The
same tool was used to extract the number of reads
mapped to the virus specific regions.
A second mapping using only enFeLV as a reference se-
quence was performed. Reads were filtered for MAPQ>
20. Using samtools, the number of mapped reads was
computed for each viral gene. Standardization was done
by dividing the number of mapped reads per viral gene by
the total number of reads per sample. To test differential
expression strength between control and tumor condition,
three two-sided Mann–Whitney U tests (with the signifi-
cance level chosen to be 0.05) were performed for each of
the three enFeLV genes (gag, pol and env). The null hy-
pothesis for the Mann–Whitney U test was that the differ-
ence in number of mapped reads between control and
tumor condition for a given gene is zero. The alternative
hypothesis was that the difference in number of mapped
reads per gene between control and tumor condition dif-
fers from zero. Since in each test, the same gene was
tested, it was not necessary to standardize the number of
reads by the length of the gene.
Additional file
Additional file 1: Number of sequenced reads per cat sample.
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